SCHEMBL2198223

SCHEMBL2198223

Cc1ccc(C(=O)NCc2ccco2)cc1C(=O)c1ccc(Nc2ccc(F)cc2F)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 1/20 0.52
MAPK12 P53778 1/20 0.52
MAPK11 Q15759 1/20 0.52
MAPK14 Q16539 1/20 0.52
ALDH1A1 P00352 2/20 0.48
HPGD P15428 1/20 0.48
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 1/20 0.45
POLB P06746 5/20 0.44
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
LMNA P02545 1/20 0.44
BLM P54132 1/20 0.44
CNR1 P21554 1/20 0.44
CNR2 P34972 1/20 0.44
GAA P10253 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2201356 0.86 MAPK14 (0.57) MAPK13MAPK12MAPK11MAPK14ALDH1A1
SCHEMBL2201335 0.85 MAPK14 (0.57) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2200118 0.84 MAPK14 (0.55) MAPK13MAPK12MAPK11MAPK14
SCHEMBL2202281 0.84 MAPK14 (0.55) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2198854 0.83 MAPK14 (0.59) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2199416 0.83 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14
SCHEMBL2198014 0.83 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2195634 0.83 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2195432 0.83 MAPK14 (0.54) MAPK13MAPK12MAPK11MAPK14MAPT
SCHEMBL2195818 0.82 MAPK14 (0.60) MAPK13MAPK12MAPK11MAPK14MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP claimed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US claimed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP claimed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US claimed
EP-1658263-B9 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2011-11-09 EP disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
EP-1658263-B1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA AS (DK) 2010-06-02 EP disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.